Solubilization and purification of the al-adrenergic receptor using a novel affinity resin ( hepatic membrane / digitonin / affinity chromatography / prazosin / antibodies )
R. Graham,HANS-JURGEN HESSt,C. Homcy
Abstract:The highly selective a1-adrenergic receptor antagonist prazosin was used to identify binding sites having a-adrenergic specificity in rat hepatic plasma membranes. Solubilization ofthe membrane-bound receptors was achieved by incubation with the nonionic detergent digitonin, and binding activity was assayed by using [3H]prazosin and a polyethylene glycol precipitation technique. Only 20-30% of the total receptor pool was released by the solubilization procedure. However, binding of [3H]prazosin was saturable [maximal value, 206 ± 8 fmol/mg of protein (membrane) vs. 74 ± 4 fmol/mg of protein (soluble)] and of high affinity [Kd, 0.6 ± 0.2 nM (membrane) vs. 0.8 ± 0.2 nM (soluble)]. To aid in purification of the receptors, an affinity resin was developed using an analog of prazosin, 2-(4-succinoylpiperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline (CP 57,609; kd 2.7 X 10-7 M) immobilized via an amide linkage to agarose. The resultingresin demonstrated high affinity (kd 3.2 x 10-7 M) for the solubilized receptors, as determined by competitive inhibition assay. The degree of substitution to the resin was determined by a direct radioimmunoassay using antibodies against albumin-complexed CP 57,609 and found to be 0.1 to 0.a2 ,umol/ml of agarose. Affinity chromatography using the resin resulted in 513-fold purification in a single step. Moreover, the specificity of the purified binding sites was similar to that of membrane-bound receptors. This novel affinity resin should thus provide a powerful tool for isolating the receptor protein in quantities sufficient for detailed biochemical characterization. a-Adrenergic receptors have been identified on the basis of pharmacologic and radioligand binding studies in a number of tissues (1). Recently, these receptors have been subclassified on the basis of their relative affinities for a variety of a-adrenergic agonists and antagonists into aland a2-subtypes (2, 3). However, little progress has been made in the elucidation of their molecular characteristics, as the techniques required for their solubilization and purification have not been available. Prazosin (2-[4-(2-furoyl)-piperazin-1-yl]-4-amino-6,7-dimethoxyquinazoline) is a highly selective acl-adrenergic antagonist (4) synthesized by Hess (5) and widely used in the management of hypertension (6). Using a structural analog of prazosin, CP 57,609 [2-(4-succinoylpiperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline] (Fig. 1), we have developed an affinity resin and used it to purify a1-adrenergic receptors solubilized from rat hepatic plasma membranes. MATERIALS AND METHODS Reagents. Guanidine hydrochloride, (-)-epinephrine, (-)norepinephrine, (.-)-phenylephrine, (-)-isoproterenol, 1-ethyl3-(3-dimethylaminopropyl)carbodiimide-HCl, bovine y-globuFIG. 1. Structures of the a,-adrenergic specific antagonist prazosin and its analog CP 57,609. Affinity of the ligands for rat hepatic membrane (particulate) receptors and affinity-purified binding sites was determined by competitive inhibition studies using [3H]prazosin (2.4 nM) asthe radioligand. ApparentKd values were derivedfrom 50% inhibitory concentrations as described by Cheng and Prusoff (7). lin, polyethylene glycol, and human serum albumin (fat free) were purchased from Sigma; phentolamine was from Ciba-Geigy; digitonin and ascorbic acid were from Fisher; agarose (Sepharose 4B) and Sephadex G-50 were from Pharmacia; CNBr was from Kodak; GF/C filters were from Scientific Products; [3H]prazosin was from Amersham; and (-)-[3H]dihydroalprenolol, Aquasol 2, and Protosol were from New England Nuclear. The followingwere gifts: prazosin (Pfizer), rauwolscine (17a-hydroxy-20a-yohimban-16,-carboxylic acid methyl ester) (Roth, Karlsruihe, Federal Republic of Germany), (-)-alprenolol (Hassle, M6Ilndal, Sweden), and (+)-norepinephrine (Winthrop, Rensselaer, NY). All organic chemicals were purchased from Aldrich (highest grade possible). Animals (Sprague-Dawley rats, New Zealand White rabbits) were obtained from Charles River Breeding Laboratories. CP 57,609-Agarose. The synthesis of the prazosin analog CP 57,609 will be described in detail elsewhere. 3,3'-Diaminodipropylamine was coupled to agarose using CNBr activation as described by Cuatrecasas (8) with 60 ml ofSepharose 4B, 11.0 g ofCNBr, and 13.1 g of diaminodipropylamine. CP 57,609 (20 umol) was coupled to the resulting agarose amine (5 ml) by using 0.4 M water-soluble 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide-HCl in 5 ml of H20 at pH 4.75 (maintained with 0.5 M HCl) with gentle stirring for 1 hr. The reaction was then allowed to proceed with gentle shaking at room temperature for t To whom reprint requests should be addressed.